Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 969-972

  Saletti, Piercarlo ^a,c   Berthold, Dominique ^a   Ghielmini, Michele ^a   Zucca, Emanuele ^a   Fazio, Nicola ^b   Goldhirsch, Aran ^b   Cavalli, Franco ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

Adjuvant chemotherapy; ECF regimen; Gastric adenocarcinoma

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DEMOGRAPHY; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; INDWELLING CATHETER; INFECTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; SIDE EFFECT; STOMACH ADENOCARCINOMA; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34250221428     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Siewert JR, Bottcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer: 10-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449-461.
2. Kim JP, Lee JH, Kim SJ, et al: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998; 1:125-133.
3. Msika S, Benhamiche AM, Jouve JL, et al: Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 2000; 36:390-396.
4. Findlay M, Cunningham D, Norman A, et al: A phase II study in advanced gastric cancer using epirubicin and cisplatin in combination with continuous 5-fluorouracil (ECF). Ann Oncol 1994; 5:609-616.
5. Webb A, Cunningham D, Scarffe JH, et al: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997; 15:261-267.
6. Bamias A, Cunningham D, Nicolson V, et al: Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study. Br J Cancer 1995; 71:583-586.
7. Altman DG, De Stavola BL, Love SB, et al: Review of survival analyses published in cancer journals. Br J Cancer 1995; 72:511-518.
8. Selvin S: Statistical analysis of epidemiologic data. 2nd edition, New York, Oxford University Press, 1996.
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
10. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977; 35:1-39.
11. Waters JS, Norman A, Cunningham D, et al: Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomised trial. Br J Cancer 1999; 80:269-272.
12. Shimada K, Ajani JA: Adjuvant chemotherapy for gastric carcinoma patients in the past 15 years. Cancer 1999; 86:1657-1668.
13. Hermans J, Bonenkamp JJ, Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomized trials. J Clin Oncol 1993; 11:1441-1447.
14. Earle CC, Maroun JA: Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999; 35:1059-1064.
15. Mari E, Floriani I, Tinazzi A, et al: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 2000; 11:837-843.
16. Panzini I, Gianni L, Fattori PP, et al: Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomised trials and a comparison with previous meta-analyses. Tumori 2002; 88:21-27.
17. Janunger KG, Hafstrom L, Glimelius B: Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002; 168:597-608.
18. Di Costanzo F, Gasperoni S, Manzione L, et al: Post-operative chemotherapy (CT) in resected gastric cancer (GO: follow-up (FUP) vs PELF. Results of an Italian intergroup (GOIRC & GISCAD) study. Proc Am Soc Clin Oncol 2003, abstr 1189.
19. Bouche O, Ychou M, Burtin P, et al: Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol 2005; 16:1488-1497.
20. Allum W, Cunningham D, Weeden S, et al: Perioperative chemotherapy in operable gastric cancer and lower oesophageal cancer: final results of a randomized, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc Am Soc Clin Oncol 2005; (abstr 4001).